Long-Term Outcomes of PCI, CABG Compared for Multivessel CAD
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — For patients with multivessel coronary artery disease, the rates of major adverse cardiac events and safety events do not differ for those receiving percutaneous coronary intervention (PCI) with everolimus-e…
Learn MoreTicagrelor DAPT Linked to Lower Risk for Vein Graft Failure in CABG
WEDNESDAY, Aug. 17, 2022 (HealthDay News) — Ticagrelor dual antiplatelet therapy (DAPT) is associated with a reduced risk for saphenous vein graft failure compared with aspirin among patients undergoing coronary artery bypass graft surgery, according…
Learn More